CCI-779 inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif-1alpha/VEGF signaling.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples